of Publlc Health for determining the rhinoGeneral of the Army, and the Army Investigavirus immunotypes, and Dr. I^WTS Wannamaker tional Drug Review Board, the Vaccine Develop-and Dr. Steven Chapman of the Univ. of Minnement Branch, National Institutes of Allergy and sota Medical School for identification of betaInfectious Diseases. It was made with the collabo-hemolytic streptococcal strains.
140
(1). Earlier it had been shown that ADV-7 disease emerged following suppression of ADV-4 disease by ADV-4 vaccine in similar groups of trainees (2) . Whether suppression of adenovirus-associated ARD in a population immunized with both ADV-4 and ADV-7 vaccines would foster the emergence of other respiratory pathogens is an unknown and important question. Thus, a secend objective of the same study was to examine the role played by agents other than ADV-4 and ADV-7 in hospitalized trainees immunized with both vaccines.
MATERIALS AND METHODS
Study design. Five trainee cohorts (5795 men) entered the 3rd Basic Combat Training (BCT) Brigade at Fort Dix, N. J., during the study period January through April, 1970. All trainees were immunized with ADV-4 and ADV-7 vaccines in the reception center within 72 hours after arrival on post. Each cohort was formed into six training companies. One company from each cohort was studied intensively for etiology of all hospitalizations for acute respiratory disease (ARD) occurring in members of that company throughout the eight-week training period.
Vaccines. Specifications for similar ADV-4 and ADV-7 vaccines have been reported elsewhere (3) . Tablets of the ADV-4 vaccine contained between 10 3 -6 and 10 4 7 tissue culture median infectious doses (TClDoo) and the ADV-7 vaccine contained between 10 4 -6 and 10 4 -7 TCID 50 per tablet.
Sampling. All ARD hospitalizations in five study companies were examined for respiratory disease by one of the investigators within 12 hours of admission. After a brief history and physical examination, the following specimens were obtained from each man: a throat washing for viral isolation, a throat swab for isolation of betahemolytic streptococci, a nasal swab for virus isolation and an acute blood sample. Convalescent blood samples were obtained two weeks later from all individuals hospitalized before the middle of the seventh week of training.
Virology. All throat wash specimens were tested in human embryonic kidney and primary rhesus monkey kidney tissue culture monolayers. Specimens from individuals suspected of having rubella were also inoculated into African green monkey kidney tissue culture monolayers, and rubella viruses were detected by interference with an ECHO-11 virus challenge technique 2 . Viruses isolated from these systems were identified by standard methods employing neutralization or hemagglutination-inhibition techniques. Nasal swab specimens were examined in WI-38 tissue culture monolayers, incubated on roller drums at 33 C. Viruses isolated from this system were tested for chloroform and acid sensitivity by standard methods. Those strains found to be chloroform-resistant but acid-sensitive (suspect rhinoviru? strains) were identified by neutralization tests in an interlocking grid system that utilized rhinovirus immunotyping sera against rhinovirus immunotypes 1-89 and a prime strain of rhinovirus 22.
Serology. Complement-fixation (CF) tests for adenovirus, Mycoplasma pneumoniae and influenza A and B antibodies were performed on all acute and convalescent sera by standard techniques. Because recruits were immunized with polyvalent influenza vaccines, a soluble CF antigen of influenza A 2 /HK/l/68 was used in these tests to determine influenza A infection. ADV-4 and ADV-7 neutralizing (N) antibody tests on acute and convalescent sera were performed by standard methods. Rubella hemagglutination-inhibition (HI) antibody titers were determined on acute and convalescent sera from all cases of clini-cal rubella and from all other cases in which no respiratory viral or bacterial pathogens were isolated.
Bacteriology. Throat swabs were plated and streaked on 5 per cent sheep blood agar plates which were incubated for 18-24 hours at 37 C. All plates were examined for betahemolytic colonies with streptococcal morphology and suspicious colonies were subcultured. All suspect strains were grown in pure culture, tested for bacitracin disk sensitivity and identified by group reactivity, Tprotein agglutination pattern and M-protein serotype.
RESULTS
There were 911 trainees in the five intensively studied training companies; prior to commencement of eight weeks of training, all were immunized with both ADV-4 and ADV-7 live, oral vaccines. Hospital admissions in this group, as shown in table 1, were predominately due to respiratory infections.
Non-respiratory admissions. Admission criteria for hospitalization of military trainees for acute respiratory disease vary only slightly among training posts, with temperature of 100 F or greater being the primary indication for admission. Despite this, individuals were admitted to the ARD ward with rubella, who were only mildly febrile (98.6-99.8 F). Clinical rubella was seen in 14 of these individuals. The diagnosis was confirmed by isolation and antibody rise in nine, isolation alone in one (no convalescent serum was available) and fourfold or greater HI antibody response alone in four. One individual without overt rubella, admitted with fever, had a four-fold HI antibody response and, in the absence of other respiratory pathogens, was considered to have been admitted because of rubella. Three individuals were admitted to the ARD ward within six hours following an initial typhoid immunization, all with fever and complaints of "sore arm." No evidence of infection by respiratory pathogens was found in these men.
Uncomplicated acute respiratory disease admissions. ADV-7 during the first three weeks of training could be the expected consequence of immunization and thus could not be considered as evidence for naturally occurring adenovirus infections.
Seven individuals had evidence of influenza A 2 infections and, as expected, the majority (six) occurred in the first two weeks of training. Strains identical to influenza A 2 Hong Kong/68 virus were isolated from three of the seven cases, and six of seven showed fourfold or greater increase in influenza A2 CF antibody titers. Recruits were immunized with a bivalent influenza vaccine during the first or second week of training.
Rhinoviruses were the only agents isolated from 10 different individuals and of those isolates, seven were typable with available rhinovirus antisera. The following types were obtained: types 2, 26, 34, 51, and 53. No single type was found in more than two individuals. The three unidentified types were tested against 89 prototype rhinoviruses, types 1-89 and a prime rhinovirus type 22 strain. Like influenza virus, these agents were associated with illnesses that occurred early in training.
Isolation of a group A beta-hemolytic streptococcus as the sole respiratory pathogen accounted for two admissions from the same training company, during the same week. Neither strain was M-typable but both were bacitracin-sensitive and had a 12/13 T-agglutination pattern.
Two individuals proved to have herpes simplex virus as the sole respiratory pathogen. There were no influenza B virus or mycoplasma CF antibody responses.
Thus, the majority of uncomplicated ARD admissions were associated with evidence for infection by a single respiratorypathogen. Despite immunization with both ADV-4 and ADV-7 vaccines, adenovirus in- fections (primarily ADV-4) were associated with over twice as many hospitalizations (47) as nonadenovirus agents (21). ARD admissions associated with multiple pathogens. Eleven of 114 uncomplicated AUD admissions (9.8 per cent) showed evidence of infection by two or more respiratory pathogens (table 3) . Combinations of infectious agents followed no particular pattern and these admissions were distributed throughout the training cycle. Ten of 11 admissions associated with more than one respiratory pathogen involved two agents; one admission was associated with evidence of simultaneous infections by three pathogens (ADV-7, rhinovirus type 53 and influenza A 2 ). Although influenza A 2 was recovered from the throat of one individual, evidence for infections in other individuals with influenza A 2 rested solely on a fourfold or greater rise in CF antibody.
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ARD admissions not associated with infectious agents. During the course of the study, 35 admissions to ARD wards could not be associated with any respiratory disease agents, accounting for 23.5 per cent of all admissions to ARD wards and 30.7 per cent of those judged to be bonafide respiratory disease admissions. Twenty-one of the 35 admissions (60 per cent) not associated with pathogens occurred during the first three weeks of training during a time when adenovirus-associated ARD was distinctly uncommon. Likewise, 14 of 21 admissions (67 per cent) associated with nonadenovirus agents occurred in the first three weeks of training. The timing of admissions which could not be associated with known agents of respiratory disease was similar to that of nonadenovirus admissions; both types of admissions occurred earlier in the training cycle than adenovirus-associated ARD admissions.
ARD admissions complicated by pneumonia. Seventeen individuals who were admitted to ARD wards had radiologic evidence of pneumonia. Pneumonia patients represented 11.4 per cent (17/131) of all AUD admissions and 14.9 per cent of those actually judged to have respiratory disease. Table 4 summarizes the virologic, serologic and bacteriologic data obtained from these individuals upon admission. ADV-4 was isolated from one individual and in two instances only an ADV-4 neutralizing antibody response could be documented. One individual was infected with influenza A2 and this admission occurred during the first week of training. A rhinovirus (type unidentifiable) and a group A streptococcus were isolated from two other individuals. No agents were isolated from 10 cases. None of the 17 admissions were associated with a four-fold or greater rise in M. pneumoniae CF antibody. Table 5 summarizes the total number and percentage of total (for each of the various categories already described) of all ARD hospital admissions in 3rd brigade study companies. In only 23.5 per cent of all ARD admissions was a reason for and/or possible cause for hospital admission not apparent.
DISCUSSION
Earlier epidemiologic studies showed that adenoviruses (types 4, 7 and to a lesser extent type 21) are the major causes of acute febrile respiratory disease requiring hospitalization of military trainees in both the United States and in The Netherlands (2, 4) . Many other viral and bacterial pathogens (influenza A and B viruses, parainfluenza viruses, rhinoviruses, coxsackie A-21 virus, group A streptococci and M. pneumoniae) have caused sporadic ARD and some- times epidemics in military populations. However, unlike the adenoviruses, none of these agents has exhibited predictable yearly patterns of epidemic disease in military populations. Further, the basis for the rather restrictive relationship between adenoviruses and ARD in recruit populations is not fully understood. Thus, when the first large group of trainees was immunized with ADV-4 and ADV-7 vaccines, it was essential to monitor closely the effects of immunization, not only to determine vaccine efficacy, but also to see if, under these circumstances, other respiratory pathogens would emerge and exhibit a capacity to produce a major new disease problem.
The results clearly indicate that under the conditions of this particular study no other respiratory pathogens emerged to rival the prevalence of adenoviruses as the major cause of ARD hospitalizations. Adenovirusassociated ARD accounted for nearly onethird of the admissions and these were primarily due to ADV-4. Adenovirus types other than ADV-4 or ADV-7 were not isolated. The ADV-4 vaccine used was of marginal potency, and clearly less effective than the ADV-7 vaccine (1).
Although rubella virus is transmitted by the respiratory route, it seemed appropriate to exclude men with rubella from the analysis of ARD admissions. Fever and/or respiratory symptoms were minimal in all cases. It is probable that the exanthem prompted admission in most instances because of concern that any exanthem might be an early indication of meningococcal disease. That exanthem was the primary criteria for admission is further suggested by the number of clinical cases (14) versus the number of subclinical cases (one) among these 149 hospital admissions. A previous study in military recruits showed that subclinical infection with rubella virus occurred 6 to 7 times more frequently than clinical infection (5). Thus, many more subclinical cases of rubella should have been found among those hospitalized had some criteria other than exanthem been an important factor leading to hospitalization.
As expected, small numbers of influenza A 2 virus and rhinovirus-associated ARD admissions occurred early in the training cycle, whereas adenovirus-associated ARD was found during the latter part of training. Other potential viral respiratory pathogens such as influenza B, parainfluenza and coxsackie A-21 viruses were not found despite the use of appropriate isolation techniques. Herpesvirus hominis and group A streptococci were found only occasionally. Serologic evidence of M. pneumoniae infection was demonstrated in only one individual in the entire study. However, 14-day convalescent sera are not optimal for detection of antibodies following M. pneumoniae infections.
Almost one of every 10 uncomplicated ARD admissions was associated with evidence for the simultaneous occurrence of two or more respiratory infections. This points out a significant difficulty in establishing the etiologic basis of ARD hospitalizations in military training populations and raises the question of whether synergism may occur. In two previous studies of respiratory disease in military populations, the incidences of multiple infections were 8.3 and 21.0 per cent, indicating that in these populations multiple infections are not infrequent occurrences (6, 7) .
Sixty per cent of ARD admissions not associated with a recovered agent or serologic evidence of infection occurred during the first three weeks of training, a time when rhinovirus infections are most common. It is entirely possible that the addition of organ culture isolation techniques as well as rhinovirus and coronavirus serology to the battery of tests employed would reduce the number of undiagnosed cases even further. Difficulties in isolating rhinoviruses are well known (8) and optimal isolation and recovery may be achieved only when two or three different tissue culture cell lines and organ culture systems are employed simultaneously.
Few, if any, conclusions are warranted from the isolation and serologic data obtained from the 17 ARD admissions complicated by pneumonia. The mere presence of organisms in the upper respiratory tract does not necessarily reflect the cause of lower respiratory tract disease. The etiologic spectrum of pneumonia in hospitalized recruits has not been firmly established except in those few instances where the evidence for M. pneumoniae infections (in epidemic proportions) has been obtained (9) .
ADV-4 and ADV-7 vaccines are intended for control but not eradication of the two most common causes of ARD requiring hos-pitalization in recruit populations. Given ADV-4 and ADV-7 vaccines of adequate and equal potencies, coupled with proper timing of administration based upon epidemiologic data, control of disease caused by these two viruses can be achieved. This study suggests that immunoprophylaxis for non-adenovirus associated ARD (with the exception of influenza) may be more difficult because of: 1) the multiplicity of agents; 2) the unknown number of agents that are yet unidentified; and 3) the tendency for these infections to occur early in training before immunoprophylactic measures would be effective. In the absence of a simple, safe "universal" chemoprophylactic, effective against multiple respiratory pathogens, it must be questioned whether the control of non-adenovirus associated ARD (influenza excepted) in military recruit populations is a realistic and practical goal.
